Arla Foods Ingredients / Volac Whey Nutrition merger inquiry
The CMA investigated the anticipated acquisition by Arla Foods Ingredients Group P/S of Volac Whey Nutrition Holdings Limited.
Statutory timetable
| Phase 1 | Action |
| 7 November 2024 | Decision announced |
| 18 September 2024 | Launch of merger inquiry |
| 18 September 2024 to 2 October 2024 | Invitation to comment |
Phase 1
CMA decision not to refer to phase 2
7 November 2024: The CMA has decided, on the information currently available to it, not to refer the anticipated acquisition by Arla Foods Ingredients Group P/S of Volac Whey Nutrition Holdings Limited to a phase 2 investigation under the provisions of the Enterprise Act 2002, including the ‘de minimis’ exception.
The full text of the decision will be published in due course.
- (7.11.24)
Launch of merger inquiry
18 September 2024: The CMA announced the launch of its merger inquiry by notice to the parties.
- (18.9.24)
Invitation to comment: closed 2 October 2024
18 September 2024: The CMA is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invites comments on the transaction from any interested party.
Contact
Case team email: arla.volac@cma.gov.uk
Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.
Updates to this page
Last updated 7 November 2024 + show all updates
-
Phase 1 decision announced.
-
First published.